Malaria is a parasitic disease of human beings. It is transmitted in 108 countries, in total affecting around 3 billion people. In 2010, it caused an estimated 216 million cases and 655,000 deaths.

The malaria parasite is highly dependent on a unique protein for infecting new mosquitoes. This protein could be a target for the development of new drugs. Over a thousand people die from malaria ...

Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission. The new molecule acts during three phases of the disease cycle, ...

Scientists from the Walter Reed Army Institute of Research joined partners at Duke University, Florida Atlantic University and Montana State University to publish a study providing clear evidence that ...

Allowing mosquitos to feed on engineered strains of the symbiotic bacteria that naturally live in their midguts may provide the answer to preventing the malarial parasite Plasmodium from completing ...

The development and implementation of a malaria vaccine would constitute a major breakthrough for global health. Recently, numerous new candidates have entered clinical testing, following strategies ...

Malaria is a life threatening mosquito-borne blood disease. Symptoms include fever, chills, and headaches. Treatment generally involves antimalarial medications. Five types of Plasmodium parasites can ...